This protocol is judged by an institutional evaluate board, an unbiased team that critiques any clinical trials involving humans. If a review includes a Plan I drug, after the board approves the protocol as moral, the researchers really need to submit an application for an investigational new drug (IND) quantity within the FDA.Along with the doses